The Siberian State Medical University, SibMed is a public medical school in Tomsk, Russia. It was founded in May, 1878 by the decree of the Emperor Alexander II.

During the past decade, Siberian State Medical University conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 10 clinical trials were completed, i.e. on average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siberian State Medical University" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Bayer" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siberian State Medical University" #1 collaborator was "Astrakhan State Medical University" with 1 trials as a collaborator, "City Clinical Hospital №24, Department of Health City of Moscow" with 1 trials as a collaborator, "GBUZ MO "Lvovskaia Raionaia Bolnica"" with 1 trials as a collaborator, "Medical Center ON-CLINIC" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Siberian State Medical University" are "Multiple Sclerosis" (4 trials), "Diabetes Mellitus, Type 2" (3 trials), "Asthma" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Type 1 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Siberian State Medical University" in a lesser frequency.

Most popular intervention types in "Siberian State Medical University" are "Drug" (30 trials), "Other" (2 trials), "Procedure" (2 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "GDC-0853" (2 trials), "Lebrikizumab" (2 trials), "16S rRNA gene sequencing" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Siberian State Medical University" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Siberian State Medical University". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Siberian State Medical University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Siberian State Medical University, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".